Law360, New York (September 22, 2011, 6:51 PM ET) -- The Sixth Circuit on Thursday upheld the dismissal of three suits bringing state failure-to-warn claims related to generic versions of heartburn medication Reglan against Barr Pharmaceuticals Inc. and others, citing the U.S. Supreme Court's recent decision in Pliva Inc. v. Mensing.
A three-judge panel ruled that a Western District of Kentucky judge had correctly decided in 2008 to nix three suits accusing both generic-drug makers as well as the drug's brand-name manufacturers of failing to include adequate information on their product labels concerning the risk that...
6th Circ. Affirms Toss Of Generic Drug Labeling Suits
To view the full article, take a free trial now.
